Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Benign neoplasm
ADR ID BADD_A05763
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.02      Miscellaneous and site unspecified neoplasms benign
16.02.02      Neoplasms benign site unspecified NEC
16.02.02.007      Benign neoplasm
Description New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. [MeSH]
MedDRA Code 10060999
MeSH ID D009369
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Benign neoplasm NOS | Benign neoplasm of other and unspecified sites | Benign neoplasm of other specified sites | Benign neoplasm of unspecified site | Benign neoplasm | Neoplasms | Neoplasia | Neoplasias | Neoplasm | Tumors | Tumor | Cancer | Cancers | Malignancy | Malignancies | Malignant Neoplasms | Malignant Neoplasm | Neoplasm, Malignant | Neoplasms, Malignant | Benign Neoplasms | Neoplasms, Benign | Benign Neoplasm | Neoplasm, Benign
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000154%
BADD_D00157Aprepitant--
BADD_D00511Clozapine0.001223%
BADD_D00852Etonogestrel0.000799%
BADD_D00858Everolimus--
BADD_D01136Imatinib0.000280%
BADD_D01253Lenalidomide0.000820%
BADD_D01281Levonorgestrel0.001040%
BADD_D01376Melphalan0.000168%
BADD_D01418Methotrexate--
BADD_D01431Methylphenidate--
BADD_D01803Porfimer sodium--
BADD_D01835Pregabalin0.000052%
BADD_D01966Ropinirole--
BADD_D02011Sertraline hydrochloride--
BADD_D02105Tacrolimus--
BADD_D02112Tamoxifen citrate--
BADD_D02325Valdecoxib--
BADD_D02464Fingolimod0.000772%
The 1th Page    1    Total 1 Pages